MedicarePartD.guide

A non-government resource built from CMS public data

Hepatitis C drugs on Humana Basic Rx Plan (S5884-131)

Epclusa, Mavyret, Harvoni and their generics, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), New Jersey
Premium
$4.40/month
Deductible
$615.00
Change plan

2 of 6 Hepatitis C drugs are covered on this plan. All 2 require prior authorization.

4 aren't on the formulary, including sofosbuvir-velpatasvir and Mavyret.

  • Epclusa
    sofosbuvir and velpatasvir
    Covered · prior auth
    from $6,368.96
    Tier 5
  • Vosevi
    sofosbuvir
    Covered · prior auth
    $6,354.60
    Tier 5
Not on the formulary
sofosbuvir-velpatasvir, Mavyret, Harvoni, ledipasvir-sofosbuvir

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list